A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)

Institut Jules Bordet_Site Number : 0560002, Anderlecht

Investigational Site Number : 3480001, Budapest

Het Ziekenhuisnetwerk Antwerpen vzw - ZNA Middelheim_Site Number : 0560001-2, Antwerp

Het Ziekenhuisnetwerk Antwerpen vzw - ZNA Cadix_Site Number : 0560001-1, Antwerp

Investigational Site Number : 0560001, Antwerp

Investigational Site Number : 0360001, Wollongong

Investigational Site Number : 0360002, Richmond

Investigational Site Number : 3800001, Rozzano

Hospital Universitario Marqués de Valdecilla_Site Number : 7240001, Santander

Investigational Site Number : 2030002, Brno

Investigational Site Number : 2030001, Ostrava

Institut Catala d´oncologia - Badalona_Site Number : 7240002, Badalona

HOSPITAL CLINIC i PROVINCIAL BARCELONA_Site Number : 7240003, Barcelona

Investigational Site Number : 8260003, Birmingham

Investigational Site Number : 8260002, London

Investigational Site Number : 8260001, Manchester